Wilmington Savings Fund Society FSB Takes Position in Humana Inc. (NYSE:HUM)

Wilmington Savings Fund Society FSB acquired a new position in shares of Humana Inc. (NYSE:HUM) in the third quarter, Holdings Channel.com reports. The fund acquired 2,992 shares of the insurance provider’s stock, valued at approximately $948,000.

Other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Pzena Investment Management LLC lifted its stake in Humana by 538.7% during the second quarter. Pzena Investment Management LLC now owns 2,318,347 shares of the insurance provider’s stock worth $866,250,000 after purchasing an additional 1,955,375 shares during the last quarter. Marshall Wace LLP raised its holdings in shares of Humana by 118.9% during the 2nd quarter. Marshall Wace LLP now owns 1,425,302 shares of the insurance provider’s stock valued at $532,564,000 after buying an additional 774,085 shares in the last quarter. International Assets Investment Management LLC lifted its position in Humana by 261,025.1% in the 3rd quarter. International Assets Investment Management LLC now owns 738,984 shares of the insurance provider’s stock worth $2,340,660,000 after buying an additional 738,701 shares during the last quarter. FMR LLC boosted its stake in Humana by 23.4% in the third quarter. FMR LLC now owns 3,388,859 shares of the insurance provider’s stock worth $1,073,387,000 after buying an additional 643,291 shares in the last quarter. Finally, Baupost Group LLC MA bought a new position in Humana during the second quarter valued at approximately $156,933,000. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

A number of equities research analysts have recently weighed in on the stock. Cantor Fitzgerald restated a “neutral” rating and issued a $395.00 price objective on shares of Humana in a report on Tuesday, October 1st. Stephens reissued an “equal weight” rating and issued a $250.00 price target on shares of Humana in a research note on Wednesday, October 9th. Oppenheimer reduced their price objective on Humana from $400.00 to $280.00 and set an “outperform” rating on the stock in a research note on Thursday, October 3rd. Leerink Partners lowered Humana from an “outperform” rating to a “market perform” rating and lowered their target price for the company from $400.00 to $250.00 in a research note on Wednesday, October 2nd. Finally, Jefferies Financial Group lowered Humana from a “buy” rating to a “hold” rating and reduced their price target for the stock from $519.00 to $253.00 in a research report on Monday, October 7th. Twenty research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Hold” and an average target price of $304.15.

Humana Trading Up 0.5 %

HUM opened at $274.12 on Friday. The company has a quick ratio of 1.76, a current ratio of 1.76 and a debt-to-equity ratio of 0.67. Humana Inc. has a 52 week low of $213.31 and a 52 week high of $486.00. The stock has a market cap of $33.01 billion, a PE ratio of 24.28, a PEG ratio of 2.15 and a beta of 0.53. The business has a 50 day moving average of $274.13 and a 200-day moving average of $324.53.

Humana (NYSE:HUM) last announced its quarterly earnings data on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, beating the consensus estimate of $3.48 by $0.68. The business had revenue of $29.30 billion during the quarter, compared to analyst estimates of $28.66 billion. Humana had a return on equity of 13.20% and a net margin of 1.18%. Equities research analysts predict that Humana Inc. will post 16.14 earnings per share for the current fiscal year.

Humana Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Shareholders of record on Tuesday, December 31st will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.29%. The ex-dividend date of this dividend is Tuesday, December 31st. Humana’s dividend payout ratio (DPR) is presently 31.36%.

Humana Company Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.